Literature DB >> 27325812

PET-measured longitudinal flow gradient correlates with invasive fractional flow reserve in CAD patients.

Ines Valenta1, Alexander Antoniou1, Wael Marashdeh1, Thorsten Leucker2, Edward Kasper2, Steven R Jones2, Robert F Dannals1, Lilja Solnes1, Martin G Pomper1, Thomas H Schindler1,2.   

Abstract

AIMS: We aimed to evaluate whether a PET-determined longitudinal decrease in myocardial blood flow (MBF) or gradient, assumed as a more specific flow parameter for epicardial resistance, correlates with invasively measured fractional flow reserve (FFR) in coronary artery disease (CAD) patients. METHODS AND
RESULTS: In 29 patients with suspected or known CAD, myocardial perfusion and MBF in mL/g/min was determined with 13N-ammonia PET/CT during regadenoson stimulation and at rest, and corresponding myocardial flow reserve (MFR = MBF stress/MBF rest) was calculated. MBF parameters were assessed in the myocardial region with stress-related perfusion defect and with stenosis ≥50% (Region 1), without defect but with stenosis ≥50% (Region 2), or without stenosis ≥50% (Region 3). Hyperaemic MBFs were significantly lower in the mid-distal than in the mid-left ventricular myocardium in Regions 1-3 [median and IQ range: 1.57 (1.24, 1.84) vs. 1.87 (1.61, 2.00), and 1.23 (1.11, 1.86) vs. 1.89 (1.80, 1.97), and 1.78 (1.48, 2.00) vs. 1.94 (1.84, 2.05) mL/g/min, P < 0.0001]. Resulting longitudinal MBF gradient during hyperaemic flows was more pronounced in Region 2 than in Regions 1 and 3, respectively [-0.46 (-0.70, -0.10) vs. -0.17 (-0.29, -0.11) and -0.15 (-0.25, -0.09) mL/g/min, respectively, P < 0.01]. There was a significant correlation between the hyperaemic longitudinal MBF gradient and FFR (r = 0.95; P < 0.0001), while this association was less pronounced for corresponding MFR (r = 0.50; P = 0.006).
CONCLUSION: The observed close correlation between a longitudinal MBF gradient during hyperaemic flows and invasively measured FFR suggests the longitudinal flow gradient as an emerging non-invasive index of flow-limiting CAD. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2016. For permissions please email: journals.permissions@oup.com

Entities:  

Keywords:  CAD; PET; circulation; coronary stenosis; flow gradient; microvascular function; myocardial blood flow; myocardial flow reserve; myocardial perfusion

Mesh:

Year:  2017        PMID: 27325812      PMCID: PMC6279108          DOI: 10.1093/ehjci/jew116

Source DB:  PubMed          Journal:  Eur Heart J Cardiovasc Imaging        ISSN: 2047-2404            Impact factor:   6.875


  38 in total

1.  Myocardial blood flow: Putting it into clinical perspective.

Authors:  Thomas Hellmut Schindler
Journal:  J Nucl Cardiol       Date:  2015-12-28       Impact factor: 5.952

2.  Clinical evaluation of a new concept: resting myocardial perfusion heterogeneity quantified by markovian analysis of PET identifies coronary microvascular dysfunction and early atherosclerosis in 1,034 subjects.

Authors:  Nils P Johnson; K Lance Gould
Journal:  J Nucl Med       Date:  2005-09       Impact factor: 10.057

3.  Diagnostic value of PET-measured heterogeneity in myocardial blood flows during cold pressor testing for the identification of coronary vasomotor dysfunction.

Authors:  Thomas H Schindler; Xiao-Li Zhang; Gabriella Vincenti; Leila Mhiri; Rene Nkoulou; Hanjoerg Just; Osman Ratib; Francois Mach; Magnus Dahlbom; Heinrich R Schelbert
Journal:  J Nucl Cardiol       Date:  2007 Sep-Oct       Impact factor: 5.952

Review 4.  Fundamentals in clinical coronary physiology: why coronary flow is more important than coronary pressure.

Authors:  Tim P van de Hoef; Maria Siebes; Jos A E Spaan; Jan J Piek
Journal:  Eur Heart J       Date:  2015-06-01       Impact factor: 29.983

5.  Quantitative assessment of myocardial perfusion in the detection of significant coronary artery disease: cutoff values and diagnostic accuracy of quantitative [(15)O]H2O PET imaging.

Authors:  Ibrahim Danad; Valtteri Uusitalo; Tanja Kero; Antti Saraste; Pieter G Raijmakers; Adriaan A Lammertsma; Martijn W Heymans; Sami A Kajander; Mikko Pietilä; Stefan James; Jens Sörensen; Paul Knaapen; Juhani Knuuti
Journal:  J Am Coll Cardiol       Date:  2014-10-07       Impact factor: 24.094

6.  Impact of anatomical and functional severity of coronary atherosclerotic plaques on the transmural perfusion gradient: a [15O]H2O PET study.

Authors:  Ibrahim Danad; Pieter G Raijmakers; Hendrik J Harms; Martijn W Heymans; Niels van Royen; Mark Lubberink; Ronald Boellaard; Albert C van Rossum; Adriaan A Lammertsma; Paul Knaapen
Journal:  Eur Heart J       Date:  2014-04-29       Impact factor: 29.983

7.  Comparison of clinical tools for measurements of regional stress and rest myocardial blood flow assessed with 13N-ammonia PET/CT.

Authors:  Piotr J Slomka; Erick Alexanderson; Rodrigo Jácome; Moises Jiménez; Edgar Romero; Aloha Meave; Ludovic Le Meunier; Magnus Dalhbom; Daniel S Berman; Guido Germano; Heinrich Schelbert
Journal:  J Nucl Med       Date:  2012-01-06       Impact factor: 10.057

8.  Dual cardiac-respiratory gated PET: implementation and results from a feasibility study.

Authors:  Axel Martinez-Möller; Darko Zikic; René M Botnar; Ralph A Bundschuh; William Howe; Sibylle I Ziegler; Nassir Navab; Markus Schwaiger; Stephan G Nekolla
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-02-21       Impact factor: 9.236

9.  Structural alterations of the coronary arterial wall are associated with myocardial flow heterogeneity in type 2 diabetes mellitus.

Authors:  Thomas H Schindler; Alvaro D Facta; John O Prior; Jerson Cadenas; Xiao-Li Zhang; Yanjie Li; James Sayre; Jonathan Goldin; Heinrich R Schelbert
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-08-15       Impact factor: 9.236

10.  A simplified method for quantification of myocardial blood flow using nitrogen-13-ammonia and dynamic PET.

Authors:  Y Choi; S C Huang; R A Hawkins; W G Kuhle; M Dahlbom; C K Hoh; J Czernin; M E Phelps; H R Schelbert
Journal:  J Nucl Med       Date:  1993-03       Impact factor: 10.057

View more
  7 in total

Review 1.  Updates on Stress Imaging Testing and Myocardial Viability With Advanced Imaging Modalities.

Authors:  Sandeep S Hedgire; Michael Osborne; Daniel J Verdini; Brian B Ghoshhajra
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-04

Review 2.  Clinical use of cardiac PET/MRI: current state-of-the-art and potential future applications.

Authors:  Patrick Krumm; Stefanie Mangold; Sergios Gatidis; Konstantin Nikolaou; Felix Nensa; Fabian Bamberg; Christian la Fougère
Journal:  Jpn J Radiol       Date:  2018-03-10       Impact factor: 2.374

Review 3.  Myocardial perfusion imaging: Lessons learned and work to be done-update.

Authors:  Ami E Iskandrian; Vasken Dilsizian; Ernest V Garcia; Rob S Beanlands; Manuel Cerqueira; Prem Soman; Daniel S Berman; Alberto Cuocolo; Andrew J Einstein; Charity J Morgan; Fadi G Hage; Heinrich R Schelbert; Jeroen J Bax; Joseph C Wu; Leslee J Shaw; Mehran M Sadeghi; Nagara Tamaki; Philipp A Kaufmann; Robert Gropler; Sharmila Dorbala; William Van Decker
Journal:  J Nucl Cardiol       Date:  2017-11-06       Impact factor: 5.952

Review 4.  Positron Emission Tomography-Determined Hyperemic Flow, Myocardial Flow Reserve, and Flow Gradient-Quo Vadis?

Authors:  Thorsten M Leucker; Ines Valenta; Thomas Hellmut Schindler
Journal:  Front Cardiovasc Med       Date:  2017-07-17

5.  Clinically viable myocardial CCTA segmentation for measuring vessel-specific myocardial blood flow from dynamic PET/CCTA hybrid fusion.

Authors:  Marina Piccinelli; Navdeep Dahiya; Jonathon A Nye; Russell Folks; C David Cooke; Daya Manatunga; Doyeon Hwang; Jin Chul Paeng; Sang-Geon Cho; Joo Myung Lee; Hee-Seung Bom; Bon-Kwon Koo; Anthony Yezzi; Ernest V Garcia
Journal:  Eur J Hybrid Imaging       Date:  2022-02-15

6.  Post COVID-19 syndrome with impairment of flow-mediated epicardial vasodilation and flow reserve.

Authors:  Amanda Verma; Tarun Ramayya; Anand Upadhyaya; Ines Valenta; Maureen Lyons; Jonas Marschall; Farrokh Dehdashti; Robert J Gropler; Pamela K Woodard; Thomas Hellmut Schindler
Journal:  Eur J Clin Invest       Date:  2022-09-09       Impact factor: 5.722

7.  Emergence of endocardium/epicardium flow gradient as novel risk biomarker in patients with hypertrophic cardiomyopathy.

Authors:  Thomas H Schindler; Ines Valenta; Sudhir Jain
Journal:  Int J Cardiol Heart Vasc       Date:  2020-01-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.